Oct. 9 (Bloomberg) -- Merck & Co.'s cervical cancer vaccine Gardasil was given to a quarter of teenage girls last year after a $100 million marketing campaign by the drugmaker.
Oct. 9 (Bloomberg) -- Merck & Co.'s cervical cancer vaccine Gardasil was given to a quarter of teenage girls last year after a $100 million marketing campaign by the drugmaker.
